Literature DB >> 18307576

EMK: a novel program for family-based allelic and genotypic association tests on quantitative traits.

Y W Li1, E R Martin, Y J Li.   

Abstract

The QTDT program is a widely-used program for analyzing quantitative trait data, but the methods mainly test allelic association. Since the genotype of a marker is a direct observation for an individual, it is of interest to assess association at the genotypic level. In this study, we extended the allele-based association method developed by Monks and Kaplan (MK method) to genotype-based association tests for quantitative traits. We implemented a novel extended MK (EMK) program that can perform both allele- and genotype- based association tests in any pedigree structure. To evaluate the performance of EMK, we utilized simulated pedigree data and real data from our previous report of GSTO1 and GSTO2 genes in Alzheimer disease (AD). Both allele- and genotype-based EMK methods (allele-EMK and geno-EMK) showed correct type I error for various pedigree structures and admixture populations. The geno-EMK method showed comparable power to the allele-EMK test. By treating age-at-onset (AAO) as a quantitative trait, the EMK program was able to detect significant associations for rs4925 in GSTO1 (P= 0.006 for allele-EMK and P= 0.009 for geno-EMK), and rs2297235 in GSTO2 (P= 0.005 for allele-EMK and P= 0.009 for geno-EMK), which are consistent with our previous findings.

Entities:  

Mesh:

Year:  2008        PMID: 18307576     DOI: 10.1111/j.1469-1809.2008.00432.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  1 in total

1.  Association between arsenic metabolism gene polymorphisms and arsenic-induced skin lesions in individuals exposed to high-dose inorganic arsenic in northwest China.

Authors:  Lanrong Luo; Yuanyuan Li; Yanhui Gao; Lijun Zhao; Hongqi Feng; Wei Wei; Chuanying Qiu; Qian He; Yanting Zhang; Songbo Fu; Dianjun Sun
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.